Maze Therapeutics, Inc. (MAZE) SEC Filings — 2026
2 SEC filings for Maze Therapeutics, Inc. (MAZE) in 2026.
Filings
- Maze Therapeutics' Lead Drug Shows Promise in Kidney Disease Trial — 10-K · Mar 25, 2026
- Maze Therapeutics Files 8-K on Operations, Officer Changes — 8-K · Mar 25, 2026